113 related articles for article (PubMed ID: 38344334)
41. Critical Care Management of the Patient with Clostridioides difficile.
Adelman MW; Woodworth MH; Shaffer VO; Martin GS; Kraft CS
Crit Care Med; 2021 Jan; 49(1):127-139. PubMed ID: 33156122
[TBL] [Abstract][Full Text] [Related]
42. Oral Vancomycin May Be Associated With Earlier Symptom Resolution Than Metronidazole for Hospitalized Children With Nonsevere
Yin J; Kociolek LK; Same RG; Hsu AJ; Amoah J; Tamma PD
Open Forum Infect Dis; 2019 Dec; 6(12):ofz492. PubMed ID: 31950069
[TBL] [Abstract][Full Text] [Related]
43. Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement.
Antonelli M; Martin-Loeches I; Dimopoulos G; Gasbarrini A; Vallecoccia MS
Intensive Care Med; 2020 Feb; 46(2):215-224. PubMed ID: 31938827
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis.
Wang Y; Ye Z; Ge L; Siemieniuk RAC; Wang X; Wang Y; Hou L; Ma Z; Agoritsas T; Vandvik PO; Perner A; Møller MH; Guyatt GH; Liu L
BMJ; 2020 Jan; 368():l6744. PubMed ID: 31907166
[TBL] [Abstract][Full Text] [Related]
45. Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE).
Wolf J; Kalocsai K; Fortuny C; Lazar S; Bosis S; Korczowski B; Petit A; Bradford D; Croos-Dabrera R; Incera E; Melis J; van Maanen R
Clin Infect Dis; 2020 Dec; 71(10):2581-2588. PubMed ID: 31773143
[TBL] [Abstract][Full Text] [Related]
46. Expert opinion on fecal microbiota transplantation for the treatment of
Kumar V; Fischer M
Expert Opin Biol Ther; 2020 Jan; 20(1):73-81. PubMed ID: 31690143
[No Abstract] [Full Text] [Related]
47. The effect of probiotics on the incidence of Clostridioides difficile: Retrospective cohort analysis.
Saltzman T; Fazzari M; Chung S; Cunha BA; Blum S
Am J Infect Control; 2020 Feb; 48(2):184-188. PubMed ID: 31606256
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of prolonged tapered and pulsed vancomycin regimen on recurrent
Umemura T; Ota A; Mutoh Y; Norizuki C; Mizuno T; Kozaki K; Ikeda Y; Ichihara T
J Pharm Health Care Sci; 2019; 5():19. PubMed ID: 31410293
[TBL] [Abstract][Full Text] [Related]
49. Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017.
Tickler IA; Obradovich AE; Goering RV; Fang FC; Tenover FC;
Anaerobe; 2019 Dec; 60():102050. PubMed ID: 31173889
[TBL] [Abstract][Full Text] [Related]
50. Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with
Major G; Bradshaw L; Boota N; Sprange K; Diggle M; Montgomery A; Jawhari A; Spiller RC;
Gut; 2019 Jul; 68(7):1224-1231. PubMed ID: 30254135
[TBL] [Abstract][Full Text] [Related]
51. Bezlotoxumab.
Johnson S; Gerding DN
Clin Infect Dis; 2019 Feb; 68(4):699-704. PubMed ID: 30020417
[TBL] [Abstract][Full Text] [Related]
52. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).
McDonald LC; Gerding DN; Johnson S; Bakken JS; Carroll KC; Coffin SE; Dubberke ER; Garey KW; Gould CV; Kelly C; Loo V; Shaklee Sammons J; Sandora TJ; Wilcox MH
Clin Infect Dis; 2018 Mar; 66(7):e1-e48. PubMed ID: 29462280
[TBL] [Abstract][Full Text] [Related]
53. Advances in the diagnosis and treatment of Clostridium difficile infections.
Peng Z; Ling L; Stratton CW; Li C; Polage CR; Wu B; Tang YW
Emerg Microbes Infect; 2018 Feb; 7(1):15. PubMed ID: 29434201
[TBL] [Abstract][Full Text] [Related]
54. The Rise and Fall of Metronidazole for Clostridium difficile Infection.
Chahine EB
Ann Pharmacother; 2018 Jun; 52(6):600-602. PubMed ID: 29424238
[TBL] [Abstract][Full Text] [Related]
55. Clostridioides (Clostridium) difficile infection in hospitalized patients with antibiotic-associated diarrhea: A systematic review and meta-analysis.
Nasiri MJ; Goudarzi M; Hajikhani B; Ghazi M; Goudarzi H; Pouriran R
Anaerobe; 2018 Apr; 50():32-37. PubMed ID: 29408016
[TBL] [Abstract][Full Text] [Related]
56. The Recent Emergence of
Popescu GA; Serban R; Pistol A; Niculcea A; Preda A; Lemeni D; Macovei IS; Tălăpan D; Rafila A; Florea D
Balkan Med J; 2018 Mar; 35(2):191-195. PubMed ID: 29188783
[TBL] [Abstract][Full Text] [Related]
57. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
[TBL] [Abstract][Full Text] [Related]
58. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection.
Cao F; Chen CX; Wang M; Liao HR; Wang MX; Hua SZ; Huang B; Xiong Y; Zhang JY; Xu YL
J Hosp Infect; 2018 Jan; 98(1):4-13. PubMed ID: 28842261
[TBL] [Abstract][Full Text] [Related]
59. Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.
Peng Z; Jin D; Kim HB; Stratton CW; Wu B; Tang YW; Sun X
J Clin Microbiol; 2017 Jul; 55(7):1998-2008. PubMed ID: 28404671
[TBL] [Abstract][Full Text] [Related]
60. European consensus conference on faecal microbiota transplantation in clinical practice.
Cammarota G; Ianiro G; Tilg H; Rajilić-Stojanović M; Kump P; Satokari R; Sokol H; Arkkila P; Pintus C; Hart A; Segal J; Aloi M; Masucci L; Molinaro A; Scaldaferri F; Gasbarrini G; Lopez-Sanroman A; Link A; de Groot P; de Vos WM; Högenauer C; Malfertheiner P; Mattila E; Milosavljević T; Nieuwdorp M; Sanguinetti M; Simren M; Gasbarrini A;
Gut; 2017 Apr; 66(4):569-580. PubMed ID: 28087657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
